New appointment at Généthon
This article was originally published in Scrip
Dr Frédéric Revah has been appointed chief executive of Généthon, the not-for-profit biotherapy research centre created by the French Muscular Dystrophy Association (AFM) and funded with donations from the country's annual Telethon. Dr Revah has more than 20 years' experience in the pharmaceutical and biotech industries and in academic research, with particular expertise in the management of therapeutic innovation. Most recently he was CEO of the oncology start-up Sepal Pharma.